Human leukocyte antigens and Epstein-Barr virus-associated nasopharyngeal carcinoma: Old associations offer new clues into the role of immunity in infection-associated cancers

Frontiers in Oncology

Volumn 3 DEC, Issue , 2013, Pages

  Su, Wen Hui ^a,b   Hildesheim, Allan ^c   Chang, Yu Sun ^b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

EBV; Genome wide association study; HLA antigens; Infection associated cancers; Nasopharyngeal carcinoma

Indexed keywords

BURKITT LYMPHOMA; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; GABBR1 GENE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; HCG9 GENE; HLA ANTIGEN GENE; HODGKIN DISEASE; HUMAN; LIVER CELL CARCINOMA; LUNG CANCER; MAJOR HISTOCOMPATIBILITY COMPLEX; NASOPHARYNX CARCINOMA; NONHUMAN; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS;

EID: 84892397844     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00299     Document Type: Review

References (56)

1. Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma. Lancet (1997) 350(9084):1087-91. doi: 10.1016/S0140-6736(97)07269-3.
2. Boyle P, Levin B. World Cancer Report 2008: International Agency for Research on Cancer. Lyon: WHO Press (2008).
3. Yu MC, Jian-Min Y. Nasopharyngeal cancer. 3rd Ed. In: Schottenfeld D, Fraumeni JF editors. Cancer Epidemiology and Prevention. Oxford, NY: Oxford University Press (2006). p. 603-19.
4. zur Hausen H, Schulte-Holthausen H, Klein G, Henle W, Henle G, Clifford P, et al. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature (1970) 228(5276):1056-8. doi:10.1038/2281056a0.
5. Longnecker RM, Kieff E, Cohen J. Epstein-Barr virus. 6th ed. In: Knipe DM, Howley PM editors. Fields Virology (Vol. 1), Philadelphia: Wolters Kluwer (2013). p. 2606-700.
6. Nikolich-Zugich J, Fremont DH, Miley MJ, Messaoudi I. The role of MHC polymorphism in anti-microbial resistance. Microbes Infect (2004) 6(5):501-12. doi:10.1016/j.micinf.2004.01.006.
7. Simons MJ, Wee GB, Day NE, Morris PJ, Shanmugaratnam K, De-The GB. Immunogenetic aspects of nasopharyngeal carcinoma: I. Differences in HL-A antigen profiles between patients and control groups. Int J Cancer (1974) 13(1):122-34. doi:10.1002/ijc.2910130114.
8. Chang ET, Adami HO. The enigmatic epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev (2006) 15(10):1765-77. doi:10.1158/1055-9965.EPI-06-0353.
9. Hildesheim A, Wang CP. Genetic predisposition factors and nasopharyngeal carcinoma risk: a review of epidemiological association studies, 2000-2011: Rosetta Stone for NPC: genetics, viral infection, and other environmental factors. Semin Cancer Biol (2012) 22(2):107-16. doi:10.1016/j.semcancer.2012.01.007.
10. Tse KP, Su WH, Chang KP, Tsang NM, Yu CJ, Tang P, et al. Genome-wide association study reveals multiple nasopharyngeal carcinoma-associated loci within the HLA region at chromosome 6p21.3. Am J Hum Genet (2009) 85(2):194-203. doi:10.1016/j.ajhg.2009.07.007.
11. Bei JX, Li Y, Jia WH, Feng BJ, Zhou G, Chen LZ, et al. A genome-wide association study of nasopharyngeal carcinoma identifies three new susceptibility loci. Nat Genet (2010) 42(7):599-603. doi:10.1038/ng.601.
12. Tang M, Lautenberger JA, Gao X, Sezgin E, Hendrickson SL, Troyer JL, et al. The principal genetic determinants for nasopharyngeal carcinoma in China involve the HLA class I antigen recognition groove. PLoS Genet (2012) 8(11):e1003103. doi:10.1371/journal.pgen.1003103.
13. Margulies DH, NAtarajan K, Rossjohn J, MacCluslory J. The major histocompatibility complex and its proteins. 7th Ed. In: Paul WE editor. Fundamental Immunology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins (2013). p. 487-523.
14. Bei JX, Jia WH, Zeng YX. Familial and large-scale case-control studies identify genes associated with nasopharyngeal carcinoma. Semin Cancer Biol (2012) 22(2):96-106. doi:10.1016/j.semcancer.2012.01.012.
15. Lu SJ, Day NE, Degos L, Lepage V, Wang PC, Chan SH, et al. Linkage of a nasopharyngeal carcinoma susceptibility locus to the HLA region. Nature (1990) 346(6283):470-1. doi:10.1038/346470a0.
16. Lu CC, Chen JC, Jin YT, Yang HB, Chan SH, Tsai ST. Genetic susceptibility to nasopharyngeal carcinoma within the HLA-A locus in Taiwanese. Int J Cancer (2003) 103(6):745-51. doi:10.1002/ijc.10861.
17. Lu CC, Chen JC, Tsai ST, Jin YT, Tsai JC, Chan SH, et al. Nasopharyngeal carcinoma-susceptibility locus is localized to a 132 kb segment containing HLA-A using high-resolution microsatellite mapping. Int J Cancer (2005) 115(5):742-6. doi:10.1002/ijc.20946.
18. Hardy J, Singleton A. Genome wide association studies and human disease. N Engl J Med (2009) 360(17):1759-68. doi:10.1056/NEJMra0808700.
19. Ng CC, Yew PY, Puah SM, Krishnan G, Yap LF, Teo SH, et al. A genome-wide association study identifies ITGA9 conferring risk of nasopharyngeal carcinoma. J Hum Genet (2009) 54(7):392-7. doi:10.1038/jhg.2009.49.
20. Hsu WL, Tse KP, Liang S, Chien YC, Su WH, Yu KJ, et al. Evaluation of human leukocyte antigen-A (HLA-A), other non-HLA markers on chromosome 6p21 and risk of nasopharyngeal carcinoma. PLoS One (2012) 7(8):e42767. doi:10.1371/journal.pone.0042767.
21. Urayama KY, Jarrett RF, Hjalgrim H, Diepstra A, Kamatani Y, Chabrier A, et al. Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. J Natl Cancer Inst (2012) 104(3):240-53. doi:10.1093/jnci/djr516.
22. Enciso-Mora V, Broderick P, Ma Y, Jarrett RF, Hjalgrim H, Hemminki K, et al. A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). Nat Genet (2010) 42(12):1126-30. doi:10.1038/ng.696.
23. Cozen W, Li D, Best T, Van Den Berg DJ, Gourraud PA, Cortessis VK, et al. A genome-wide meta-analysis of nodular sclerosing Hodgkin lymphoma identifies risk loci at 6p21.32. Blood (2012) 119(2):469-75. doi:10.1182/blood-2011-03-343921.
24. Shi Y, Hu Z, Wu C, Dai J, Li H, Dong J, et al. A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1. Nat Genet (2011) 43(12):1215-8. doi:10.1038/ng.978.
25. Saeki N, Ono H, Sakamoto H, Yoshida T. Genetic factors related to gastric cancer susceptibility identified using a genome-wide association study. Cancer Sci (2013) 104(1):1-8. doi:10.1111/cas.12042.
26. Abnet CC, Freedman ND, Hu N, Wang Z, Yu K, Shu XO, et al. A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma. Nat Genet (2010) 42(9):764-7. doi:10.1038/ng.649.
27. Jin G, Ma H, Wu C, Dai J, Zhang R, Shi Y, et al. Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese. Am J Hum Genet (2012) 91(5):928-34. doi:10.1016/j.ajhg.2012.09.009.
28. Chen D, Juko-Pecirep I, Hammer J, Ivansson E, Enroth S, Gustavsson I, et al. Genome-wide association study of susceptibility loci for cervical cancer. J Natl Cancer Inst (2013) 105(9):624-33. doi:10.1093/jnci/djt051.
29. Shi Y, Li L, Hu Z, Li S, Wang S, Liu J, et al. A genome-wide association study identifies two new cervical cancer susceptibility loci at 4q12 and 17q12. Nat Genet (2013) 45(8):918-22. doi:10.1038/ng.2687.
30. Kumar V, Kato N, Urabe Y, Takahashi A, Muroyama R, Hosono N, et al. Genome-wide association study identifies a susceptibility locus for HCV-induced hepatocellular carcinoma. Nat Genet (2011) 43(5):455-8. doi:10.1038/ng.809.
31. Li S, Qian J, Yang Y, Zhao W, Dai J, Bei JX, et al. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet (2012) 8(7):e1002791. doi:10.1371/journal.pgen.1002791.
32. Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet (2013) 45(1):72-5. doi:10.1038/ng.2483.
33. Kim YJ, Kim HY, Lee JH, Yu SJ, Yoon JH, Lee HS, et al. A genome-wide association study identified new variants associated with the risk of chronic hepatitis B. Hum Mol Genet (2013) 22(20):4233-8. doi:10.1093/hmg/ddt266.
34. Clifford RJ, Zhang J, Meerzaman DM, Lyu MS, Hu Y, Cultraro CM, et al. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology (2010) 52(6):2034-43. doi:10.1002/hep.23943.
35. Lan Q, Hsiung CA, Matsuo K, Hong YC, Seow A, Wang Z, et al. Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia. Nat Genet (2012) 44(12):1330-5. doi:10.1038/ng.2456.
36. Trevino LR, Yang W, French D, Hunger SP, Carroll WL, Devidas M, et al. Germline genomic variants associated with childhood acute lymphoblastic leukemia. Nat Genet (2009) 41(9):1001-5. doi:10.1038/ng.432.
37. Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, Olver B, Sheridan E, et al. Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia. Nat Genet (2009) 41(9):1006-10. doi:10.1038/ng.430.
38. Ellinghaus E, Stanulla M, Richter G, Ellinghaus D, te Kronnie G, Cario G, et al. Identification of germline susceptibility loci in ETV6-RUNX1-rearranged childhood acute lymphoblastic leukemia. Leukemia (2012) 26(5):902-9. doi:10.1038/leu.2011.302.
39. Yang JJ, Cheng C, Devidas M, Cao X, Campana D, Yang W, et al. Genome-wide association study identifies germline polymorphisms associated with relapse of childhood acute lymphoblastic leukemia. Blood (2012) 120(20):4197-204. doi:10.1182/blood-2012-07-440107.
40. Kim DH, Lee ST, Won HH, Kim S, Kim MJ, Kim HJ, et al. A genome-wide association study identifies novel loci associated with susceptibility to chronic myeloid leukemia. Blood (2011) 117(25):6906-11. doi:10.1182/blood-2011-01-329797.
41. Kumar V, Matsuo K, Takahashi A, Hosono N, Tsunoda T, Kamatani N, et al. Common variants on 14q32 and 13q12 are associated with DLBCL susceptibility. J Hum Genet (2011) 56(6):436-9. doi:10.1038/jhg.2011.35.
42. Rubicz R, Yolken R, Drigalenko E, Carless MA, Dyer TD, Bauman L, et al. A genome-wide integrative genomic study localizes genetic factors influencing antibodies against Epstein-Barr virus nuclear antigen 1 (EBNA-1). PLoS Genet (2013) 9(1):e1003147. doi:10.1371/journal.pgen.1003147.
43. International HIV Controllers Study, Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, et al. The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science (2010) 330(6010):1551-7. doi:10.1126/science.1195271.
44. Skibola CF, Bracci PM, Halperin E, Conde L, Craig DW, Agana L, et al. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet (2009) 41(8):873-5. doi:10.1038/ng.419.
45. Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 42(8):661-4. doi:10.1038/ng.626.
46. Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, Hjalgrim H, et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet (2011) 7(4):e1001378. doi:10.1371/journal.pgen.1001378.
47. Slager SL, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, et al. Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL. Blood (2011) 117(6):1911-6. doi:10.1182/blood-2010-09-308205.
48. Slager SL, Skibola CF, Di Bernardo MC, Conde L, Broderick P, McDonnell SK, et al. Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. Blood (2012) 120(4):843-6. doi:10.1182/blood-2012-03-413591.
49. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 45(8):868-76. doi:10.1038/ng.2652.
50. Vijai J, Kirchhoff T, Schrader KA, Brown J, Dutra-Clarke AV, Manschreck C, et al. Susceptibility loci associated with specific and shared subtypes of lymphoid malignancies. PLoS Genet (2013) 9(1):e1003220. doi:10.1371/journal.pgen.1003220.
51. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet (2008) 40(12):1407-9. doi:10.1038/ng.273.
52. Landi MT, Chatterjee N, Yu K, Goldin LR, Goldstein AM, Rotunno M, et al. A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma. Am J Hum Genet (2009) 85(5):679-91. doi:10.1016/j.ajhg.2009.09.012.
53. Shiraishi K, Kunitoh H, Daigo Y, Takahashi A, Goto K, Sakamoto H, et al. A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat Genet (2012) 44(8):900-3. doi:10.1038/ng.2353.
54. Rapley EA, Turnbull C, Al Olama AA, Dermitzakis ET, Linger R, Huddart RA, et al. A genome-wide association study of testicular germ cell tumor. Nat Genet (2009) 41(7):807-10. doi:10.1038/ng.394.
55. Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, et al. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 43(8):785-91. doi:10.1038/ng.882.
56. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, et al. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 45(4):385-91. doi:10.1038/ng.2560.